Advances in the chemistry of nanosized zirconium phosphates: a new mild and quick route to the synthesis of nanocrystals

Simple addition of zirconyl propionate to phosphoric acid in alcoholic media surprisingly led to the formation, in few minutes, of transparent gels containing solvent intercalated zirconium phosphate (ZrP) nanoparticles with hexagonal shape and a planar size of about 40 nm. With the help of elemental analysis, inductively coupled plasma-optical emission spectrometry (ICP-OES), and (31)P magic angle spinning (MAS) NMR, the nanoparticle composition was formulated as Zr(R)(w)(HPO(4))(x)(H(2)PO(4))(y), in which R can be an hydroxyl or a propionate group. The stoichiometric coefficients for propanol intercalated ZrP are x = 1.43, y = 0.83, and w = 0.32. Solvent elimination at 60 °C gave rise to an increase in the x value and a decrease in the y and w values. X-ray powder diffraction analysis and transmission electron microscopy (TEM) observations showed a concomitant increase in the particle size: planar size and thickness ranged from 90 to 200 nm and from 20 to 85 nm, respectively, depending on the nature of the solvent. A possible mechanism explaining the change in the x, y, and w values, the growth of nanoparticles, and the role of the solvent is proposed. Finally, the possibility of using these gels to disperse the ZrP nanoparticles within the polymer matrix of Nafion117 is shown.     

Design,synthesis of novel quinazolin-4-one derivatives and biological evaluation against human MCF-7 breast cancer cell line

A new series of 6,8-dibromo-2-(4-chlorophenyl)quinazolin-4(3H)-one derivatives VI–XIII were synthesized. Their chemical structures were confirmed by spectral and elemental analysis. The cytotoxic effect of the newly synthesized compounds was tested in vitro against human breast cancer cell line (MCF-7). Most of the tested compounds have shown promising cytotoxic activity. Compounds X and XIIIb exerted a powerful cytotoxic effect against MCF-7 with a very low IC50 (0.0015 and 0.0047 µmol/ml), while compounds VI, VII, VIII, XIIb, XI, XIIIc and IX exerted a moderate cytotoxic effect (IC50 0.01523, 0.0213, 0.031, 0.0478, 0.049, 0.068 and 0.079 µmol/ml respectively), compared to doxorubicin (0.0025 µmol/ml). Exploring their apoptotic effect; interestingly,all compounds activated apoptotic cascade in MCF-7. Compounds VI, XIIIb, XIIb, XI, XIIa, VII, V and VIII showed potent effect even much more than doxorubicin by 12.87–5.91 folds, while compounds XIIIc, IX, XIIIa, XIIc and X showed moderate increase in CASP3 activity by 4.96–3.22 folds relative to untreated cells more or less similar to doxorubicin (5.57 folds).     

Layered inorganic materials as redox agents: ferrocenium-intercalated zirconium phosphate

The direct intercalation reaction of ferrocene (bis(eta5-cyclopentadienyl)iron(II), Fc) with a highly hydrated layered zirconium phosphate (ZrP) resulted in the formation of the ferrocenium ion (Fc+) within the ZrP material. The Fc+-intercalated ZrP material has an interlayer distance of 10.7 A. The intercalated material was used as an electron acceptor for the oxidation of both ferro-cytochrome c and the excited state of tris(2,2'-bipyridine)ruthenium(II) ([Ru(bpy)3]2+). Upon contact of the material with a 1.5 x 10(-5) M solution of ferro-cytochrome c, the UV-vis absorption spectrum shows the successful formation of ferri-cytochrome c. Luminescence spectroscopy shows that the Fc+-intercalated ZrP material quenches the luminescence of [Ru(bpy)3]2+. The excited-state quenching mechanism of [Ru(bpy)3]2+* by Fc+-intercalated ZrP follows a dynamic plus sphere of action model. The second-order dynamic quenching rate constant kq is 2.2 x 10(8) M(-1) s(-1).     

Intercalation and photophysical characterization of 1-pyrenemethylamine in zirconium phosphate layered materials

The ion exchange of the luminescent probe 1-pyrenemethylamine (PYMA) into zirconium phosphate (ZrP) layered materials has been accomplished. The matrices used were the hexahydrated 10.3 A phase of ZrP (10.3 A ZrP, where 10.3 A represents the interlayer distance) and butylammonium-exchanged ZrP (BAZrP) with an expanded 18.6 A interlayer distance. The XRPD patterns for the 10.3 A ZrP after PYMA exchange (PYMA-exchanged ZrP), at high PYMA concentrations, show an increase in the interlayer distance from 10.3 A in unexchanged 10.3 A ZrP to 23.5 A in PYMA-exchanged ZrP, indicating PYMA intercalation. The luminescence spectrum for the PYMA-exchanged ZrP exhibits an excimer band at 458 nm that is absent in the luminescence spectrum of PYMA in aqueous solution at low concentrations. The intensity of the excimer emission increased at low PYMA concentrations. These results are in contrast to experiments using the BAZrP matrix. The XRPD patterns for PYMA-exchanged BAZrP do not show changes in the interlayer distance, which suggests that PYMA is not being intercalated and is only surface bound. The luminescence spectrum for PYMA-exchanged BAZrP exhibits a lower emission intensity in its excimer band, at different PYMA concentrations, compared with the PYMA-exchanged ZrP excimer band. For PYMA-exchanged ZrP, we propose a process in which exchange at low PYMA concentrations occurs at external surface sites with clustering promoting excimer formation followed by exchange at high PYMA concentrations occurring at interior sites reducing excimer formation.     

Room-temperature emission from platinum(II) complexes intercalated into zirconium phosphate-layered materials

The direct ion exchange of chloro(2,6-bis(N-methylbenzimidazol-2-yl)pyridine)platinum(II) ([Pt(Me(2)bzimpy)Cl]+) and chloro(2,2':6',2' '-terpyridine)platinum(II) ([Pt(tpy)Cl]+) complexes within a zirconium phosphate (ZrP) framework has been accomplished. The physical and spectroscopic properties of [Pt(Me(2)bzimpy)Cl]+ and [Pt(tpy)Cl]+ intercalated in ZrP were investigated by X-ray powder diffraction and X-ray photoelectron, infrared, absorption, and luminescence spectroscopies. In contrast to unintercalated complexes in fluid solution, which do not emit at room temperature, both intercalated materials in the solid state and in colloidal suspensions exhibit intense emissions at room temperature. A [Pt(Me(2)bzimpy)Cl]+-exchanged ZrP colloidal methanol suspension gives rise to an emission at 612 nm that originates from a lowest (3)MMLCT[dsigma*(Pt) --> pi*(tpy)] state (MMLCT = metal-metal-to-ligand charge transfer) characteristic of strong Pt...Pt interactions. A [Pt(tpy)Cl]+-exchanged ZrP colloidal aqueous suspension exhibits a strong emission band at 600 nm. The accumulated data demonstrate that at high concentrations, [Pt(Me(2)bzimpy)Cl]+ and [Pt(tpy)Cl]+ ions can serve as luminescent pillars inside the ZrP framework.     

Effect of Enzyme and Cofactor Immobilization on the Response of Ethanol Oxidation in Zirconium Phosphate Modified Biosensors

Two different self‐contained ethanol amperometric biosensors incorporating layered [Ru(phend)₂bpy]²⁺‐intercalated zirconium phosphate (ZrP) as the mediator as well as yeast‐alcohol dehydrogenase (y‐ADH) and its cofactor nicotinamide adenine dinucleotide (NAD⁺) were constructed to improve upon a design previously reported where only this mediator was immobilized in the surface of a modified electrode. In the first biosensor, a [Ru(phend)₂bpy]²⁺‐intercalated ZrP modified carbon paste electrode (CPE) was improved by immobilizing in its surface both y‐ADH and NAD⁺ using quaternized Nafion membrane. In the second biosensor, a glassy carbon electrode was modified with [Ru(phend)₂bpy]²⁺‐intercalated ZrP, y‐ADH, and NAD⁺ using Nafion as the holding matrix. Calibration plots for ethanol sensing were constructed in the presence and absence of ZrP. In the absence of ZrP in the surface of the modified glassy carbon electrode, leaching of ADH was observed as detected by UV‐vis spectrophotometry. Ethanol sensing was also tested in the presence and absence of ascorbate to measure the selectivity of the sensor for ethanol. These two ethanol biosensors were compared to a previously reported one where the y‐ADH and the NAD⁺ were in solution, not immobilized.     

Luminescence rigidochromism and redox chemistry of pyrazolate-bridged binuclear platinum(II) diimine complex intercalated into zirconium phosphate layers

The direct intercalation of a pyrazolate-bridged platinum(II) bipyridyl dimer ([{Pt(dmbpy)(μ-pz)}(2)](2+); dmbpy = 4,4'-dimethyl-2,2'-bipyridine, pz(-) = pyrazolate) within a zirconium phosphate (ZrP) framework has been accomplished. The physical and spectroscopic properties of [{Pt(dmbpy)(μ-pz)}(2)](2+) intercalated in ZrP were investigated by X-ray powder diffraction and X-ray photoelectron, infrared, absorption, and luminescence spectroscopies. Zirconium phosphate layers have a special microenvironment that is capable of supporting a variety of platinum oxidation states. Diffuse reflectance spectra from powders of the blue-gray intercalated materials show the formation of a low-energy band at 600 nm that is not present in the platinum dimer salt. The nonintercalated complex is nonemissive in room-temperature fluid solution, but gives rise to intense blue-green emission in a 4:1 ethanol/methanol 77 K frozen glassy solution. Powders and colloidal suspensions of [{Pt(dmbpy)(μ-pz)}(2)](2+)-exchanged ZrP materials exhibit intense emissions at room-temperature.     

Glucose sensor based on glucose oxidase immobilized by zirconium phosphate.

Amperometric glucose sensors were fabricated using glucose oxidase (GOx) entrapped in zirconium hydrogenphosphate (ZrP), and their performance was evaluated. Reportedly, alpha-ZrP is one of the candidates that are expected to improve the stability of enzymes immobilized on solid surfaces. We intercalated GOxs into ZrP (GOx/ZrP), cast the GOx/ZrP suspension in polyvinylalcohol on a platinum electrode, and dried it in a vacuum oven. The morphological layered structure was investigated by scanning electron microscopy. The enzymatic activities, which were determined by open-circuit potentiometric technique, reached the highest when GOxs were immobilized in ZrP at ca. pH 5. In vitro tests showed good linear responses in the 0-25 mM range and the sensitivity of 0.14 nA mM(-1) at 0.4 V vs. Ag/AgCl. The sensors, as made, were stable for more than 3 days within a limited deterioration.     

Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells

Meta-tetra(hydroxyphenyl)chlorin (mTHPC) is in clinical trials for the photodynamic therapy (PDT) of localized-stage cancer. The PDT susceptibility of cells expressing multidrug resistance (MDR) phenotype is an attractive possibility to overcome the resistance to cytotoxic drugs observed during cancer chemotherapy. The accumulation, photocytotoxicity and intracellular localization of mTHPC were examined using the doxorubicin selected MCF-7/DXR human breast cancer cells, expressing P-glycoprotein (P-gp), and the wild-type parental cell line, MCF-7. No significant difference in mTHPC accumulation was observed between the two cell lines up to 3 h contact. The photodynamic activity of mTHPC, measured 24 h after irradiation with red laser light (lambda=650 nm), was significantly greater in MCF-7/DXR as compared to MCF-7 cells. A light dose of 2.5 J cm(-2) inducing 50% of cytotoxicity in MCF-7, resulted in 85% cytotoxicity in MCF-7/DXR. The presence of P-gp inhibitors SDZ-PSC-833 and cyclosporin A did not modify the mTHPC-induced cytotoxicity. The difference in intracellular mTHPC distribution pattern between two cell lines may contribute to different photocytotoxicity. Our results indicate that mTHPC mediated PDT could be useful in killing cells expressing MDR phenotype.     

Reversal effects of traditional Chinese herbs on multidrug resistance in cancer cells

Multidrug resistance (MDR) continues to be a major obstacle for successful anticancer therapy. In this work, fractions from 17 clinically used antitumour traditional Chinese medicinal herbs were tested for their potential to restore the sensitivity of MCF-7/ADR and A549/Taxol cells to a known antineoplastic agent. The effects of these fractions were evaluated by MTT method and an assay of the cellular accumulation of doxorubicin. Fractions from the PB group (herbs with the ability to promote blood circulation and remove blood stasis) showed more significant effects than fractions from the CH group (herbs with the ability to clear away heat and toxic materials). Fractions from CH?Cl? extracts were more effective than fractions from EtOAc extracts. Five herbs (Curcuma wenyujin, Chrysanthemum indicum, Salvia chinensis, Ligusticum chuanxiong Hort. and Cassia tora L.) could sensitise these resistant cancer cells at a non-toxic concentration (10?μg?mL?1), and markedly increased doxorubicin accumulation in MCF-7/ADR cells, which necessitates further investigations on the active ingredients of these herbs and their underlying mechanisms.     

Nanoemulsions of Jasminum humile L. and Jasminum grandiflorum L. Essential Oils: An Approach to Enhance Their Cytotoxic and Antiviral Effects

Unprecedented nanoemulsion formulations (NE) of Jasminum humile and Jasminum grandiflorum essential oils (EO) were prepared, and examined for their cytotoxic and antiviral activities. NE characterization and stability examination tests were performed to ensure formula stability. The antiviral activity was determined against hepatitis A (HAV) and herpes simplex type-1 (HSV-1) viruses using MTT assay, while the cytotoxic potential was determined against liver (HepG-2), breast (MCF-7), leukemia (THP-1) cancer cell lines and normal Vero cells. Statistical significance was determined in comparison with doxorubicin as cytotoxic and acyclovir as antiviral standard drugs. GC-MS analysis indicated twenty four compounds in the EO of J. humile and seventeen compounds in the EO of J. grandiflorum. Biological investigations of pure EOs revealed weak cytotoxic and antiviral effects. Nevertheless, their NE formulations exhibited high biological value as cytotoxic and antiviral agents. NE formulations also showed feasible selectivity index for the viral-infected and cancer cells (especially HepG-2) than normal Vero cells. Both nanoemulsions showed lower IC₅₀ than standard doxorubicin against HepG-2 (26.65 and 22.58 vs. 33.96 μg/mL) and MCF-7 (36.09 and 36.19 vs. 52.73 μg/mL), respectively. The study results showed the dramatic effect of nanoemulsion preparation on the biological activity of EOs and other liposoluble phytopharmaceuticals.     

Intercalation of Re(phen)(CO)3Cl into zirconium phosphate: a water insoluble inorganic complex immobilized in a highly polar rigid matrix

The intercalation of fac-tricarbonylchloro-1,10-phenanthrolinerhenium(i) (Re(phen)(CO)(3)Cl) within zirconium phosphate (ZrP) has been achieved using a hydrated ZrP phase that possesses six water molecules per formula unit. This intercalation occurs only at high solution molar ratios (Re : ZrP, 3 : 1) and is characterized by the emergence of a new phase in the X-ray powder diffraction (XRPD) pattern with an interlayer distance of 15.6 A. The XRPD patterns show a decrease in the crystallinity upon intercalation of the inorganic complex. The MLCT absorption bands of Re(phen)(CO)(3)Cl-containing ZrP materials are red shifted in comparison with the complex in acetonitrile whilst the luminescence spectra at different loading levels are blue shifted up to 30 nm in comparison with the complex in acetonitrile. This blue shift is consistent with the rigidochromic effect. The luminescence lifetime of Re(phen)(CO)(3)Cl within ZrP was increased in comparison with its lifetime in acetonitrile solution but is shorter than that of Re(phen)(CO)(3)Cl in frozen glass and polyesther resins. To our knowledge, this is the first example of a water insoluble metal complex intercalated within the layers of ZrP, which opens up new possibilities in the intercalation chemistry of this lamellar material and in the study of host-guest interactions.     

Acceleration effects of 1,5,7‐triazabicyclo[4.4.0]dec‐5‐ene with 2‐methylimidazole‐intercalated α‐zirconium phosphate as a latent thermal initiator in the reaction of glycidyl phenyl ether and hexahydro‐4‐methylphthalic anhydride

The catalytic effects of 1,5,7‐Triazabicyclo[4.4.0]dec‐5‐ene (TBD) with 2‐methylimidazole‐intercalated α‐zirconium phosphate (α‐ZrP?2MIm) in the reaction of glycidyl phenyl ether (GPE) and hexahydro‐4‐methylphthalic anhydride (MHHPA) were investigated. The reaction did not proceed within 1 h at 60 °C. On increasing the temperature to 100 °C, the conversion reached 93% for 1 h. Without the addition of TBD, the conversion was 67% at 100 °C for 1 h. Under storage conditions at 25 °C for 7 days, the conversion of GPE was only 18%. The curing behavior of 2,2‐bis(4‐glycidyloxyphenyl)propane (DGEBA) and MHHPA in the presence of TBD with α‐ZrP?2MIm was evaluated by differential scanning calorimetry. The addition of TBD with α‐ZrP?2MIm as a latent thermal initiator, the storage stability was maintained and the reaction proceeded rapidly under heating conditions. © 2019 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2019 , 57, 2557–2561     

Therapeutic Potential of DNAzyme Loaded on Chitosan/Cyclodextrin Nanoparticle to Recovery of Chemosensitivity in the MCF-7 Cell Line

Commonly, acquired resistances to anticancer drug are mediated by overexpression of a membrane-associated protein that encode via multi-drug resistance gene-1 (MDR1). Herein, the mRNA-cleaving DNAzyme that targets the mRNA of MDR1 gene in doxorubicin-resistant breast cancer cell line (MCF-7/DR) loaded on the chitosan β-cyclodextrin complexes was used as a tropical agent. Chitosan/β-cyclodextrin complexes were used to deliver DNAzymes into cancer cells. Determination of the physicochemical characteristics of the particles was done by photon correlation spectroscopy and scanning electron microscopy. The encapsulation efficiency of the complexes was tested by using gel retardation assay. Positively charged nanoparticles interacted with DNAzyme that could perform as an efficient DNAzyme transfection system. The rationale usage of this platform is to sensitize MCF-7/DR to doxorubicin by downregulating the drug-resistance gene MDR1. Results demonstrated a downregulation of MDR1 mRNAs in MCF-7/DR/DNZ by real-time PCR, compared to the MCF-7/DR as control. WST1 assay showed the 22-fold decrease in drug resistance on treated cells 24 h after transfection. Results showed the intracellular accumulation of Rh123 increased in the treated cells with DNAzyme. Results suggested a potential platform in association with chemotherapy drug for cancer therapy and indicated extremely efficient at delivery of DNAzyme in restoring chemosensitivity.

     

Synthesis of mesoporous silica nanoparticles and nanorods: Application to doxorubicin delivery

The synthesis and application of mesoporous silica nanoparticles (MSN) and mesoporous silica nanorods (MSNR) for drug delivery were described. MSN or MSNR were obtained by adjusting the amount of added cosolvent to the sol-gel solution. Therefore, the addition of ethanol (EtOH) has contributed to the control of the particle shape and to the structure of the mesoporosity. MSN and MSNR particles were then loaded with doxorubicin and incubated with MCF-7 breast cancer cells. MSN and MSNR particles were efficient in killing cancer cells but their behavior in drug delivery was altered on account of the difference in their morphology. MSN showed a burst release of doxorubicin in cells whereas MSNR showed a sustained delivery of the anti-cancer drug.     

Synthesis and antitumor evaluation of some new derivatives and fused heterocyclic compounds derived from thieno[2,3-b]pyridine: Part 2

As a continuation of our research on developing anticancer agents and based on the proven proprieties of thieno[2,3-b]pyridines as anticancer, we have designed to synthesize novel thieno[2,3-b]pyridine derivatives that incorporate different biologically active heterocycles through various chemical reactions. All of the newly obtained compounds, compared with the standard anticancer drug (doxorubicin), were screened in vitro for their antitumor activity against hepatocellular carcinoma (HepG-2) and human breast cancer (MCF-7) cell lines. The results revealed that compounds 3 , 7 , 12 , and 19 were found to be the most potent against both HepG-2 and MCF-7 cell lines exhibiting IC₅₀ values ranging from 3.67 to 11.50 and 5.13 to 11.80 μg/mL, respectively, among which compound 7 has a more potent activity than the reference drug doxorubicin against HepG-2 cell line, showing IC₅₀ value of 3.67 μg/mL (doxorubicin 4.65 μg/mL).     

基于生物条形码的粘蛋白和特定细胞电化学发光适配体生物传感方法研究

本文基于适配体识别和生物条形码放大策略,以MCF-7细胞和粘蛋白(MUC1)为目标物,MUC1的特异性适配体(rcDNA)为分子识别物质,Ru(phen)32+为信号物质,rcDNA通过巯基自组装于金电极表面作为传感界面,发卡DNA (hpDNA)和rcDNA通过巯基自组装在金纳米粒子(AuNP)表面合成的hpDNA/...     

pH、富里酸和温度对铀酰在ZrP_2O_7上的吸附影响

采用质量滴定法和静态法分别研究了ZrP2O7的零电荷点(pHPZC)和铀酰离子在ZrP2O7上的吸附及解吸行为.铀酰离子在ZrP2O7上的吸附受体系pH、固液比、电解质种类及富里酸(FA)强烈影响,离子强度对铀酰离子在ZrP2O7上吸附的影响较小;随着固液比(m/V)和pH增大,吸附边界向左偏移;磷酸根与硫酸根对吸附有相反的影响;在低pH下,富里酸(FA)促进铀酰离子在ZrP2O7上吸附;柠檬酸根对吸附有非常大的影响;温度升高有利于吸附.采用Langmuir和Freundlich模型对吸附等温线进行拟合研究,表明Freundlich模型可以更好地拟合铀酰离子在ZrP2O7上的吸附.通过对热力学数据如(△H0,△S0和△G0)的计算可知吸附过程是自发和吸热过程.铀酰离子在ZrP2O7上吸附为不可逆吸附.     

Artemisinin-isatin hybrids with potential antiproliferative activity against breast cancer

Three series of artemisinin-isatin hybrids 8a-i, 10a-c and 11a-e were designed, synthesized and evaluated for their antiproliferative activity against breast cancer cells (MCF-7, MDA-MB-231 and doxorubicin-resistant MCF-7 (MCF-7/DOX)), as well as the cytotoxicity towards normal MCF-10A breast cells. The preliminary results showed that a significant part of the synthesized hybrids (IC₅₀: 20.7–99.9 µM) were active against both drug-sensitive and doxorubicin-resistant breast cancer cell lines. The structure–activity relationship illustrated that the linker between artemisinin and isatin moieties as well as the substituents on C-3 and C-5 position of isatin motif had great influence on the activity. In particular, hybrids 11c,d were found to be most active against all tested breast cancer cell lines, and their activity was not inferior to that of doxorubicin. Therefore, hybrids 11c,d could serve as useful templates for the development of novel anti-breast cancer agents.     

Synthesis and antiproliferative evaluation of some novel quinazolin-4(3H)-one derivatives

A series of novel quinazolinone derivatives was designed and synthesized. The antiproliferative activities were evaluated in vitro using MTT assay against hepatocellular carcinoma (HepG-2) and mammary gland breast cancer (MCF-7). The preliminary bioassay results demonstrated that tested compounds exhibited antiproliferation with various degrees. Triazole moiety enhanced the activity against the two cell lines when incorporating with quinazolinone moiety in a single molecular framework. Acetohydrazide-quinazolinone derivative showed strong activity against the two cancer cells comparable to that of doxorubicin. Biological evaluation indicated that all the tested compounds possessed antiproliferative activity with certain degrees.